The Sixth Peoples Hospital of Shenyang
Welcome,         Profile    Billing    Logout  
 0 Trials 
6 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Gu, Ye
NCT05182463: Peginterferon Treatment Study for Inactive Chronic Hepatitis B Patients

Recruiting
4
5000
RoW
Peginterferon Alfa-2B, Nucleoside Analogs
Third Affiliated Hospital, Sun Yat-Sen University
Hepatitis B, Chronic
12/26
11/29
NCT04883177: Effectiveness and Safety of the COVID-19 Vaccination for Patients With Liver Disease (CHESS2101)

Completed
N/A
1000
RoW
Hepatopancreatobiliary Surgery Institute of Gansu Province, LanZhou University, Huashan Hospital, The Sixth People's Hospital of Shenyang City, Xingtai City People's Hospital, Jinchang Central Hospital, Baoding People's Hospital, The Third People's Hospital of Zhenjiang City, Shanxi Bethune Hospital, Wuhan Jinyintan Hospital, Jincheng People's Hospital, The Third People's Hospital of Tibet Autonomous Region, People's Hospital of Ningxia Hui Autonomous Region, Fuling Central Hospital of Chongqing City, Hospital of the Chengdu Office of the People's Government of Tibet Autonomous Region, The Central Hospital of Lishui City, The Third People's Hospital of Linfen City, Yibin First People's Hospital, Jingzhou Central Hospital, Wuxi Fifth People's Hospital, Qingyang People's Hospital, The First Affiliated Hospital of Anhui Medical University, Beilun Hospital of Traditional Chinese Medicine, Henan Provincial People's Hospital, Qingdao Sixth People's Hospital, The First Affiliated Hospital of Xiamen University, Shandong Provincial Hospital, Beijing YouAn Hospital, The First People's Hospital of Taicang, The Third People's Hospital of Taiyuan, Tianjin Second People's Hospital, Tianjin Third Central Hospital, Qishan Hospital of Yantai City, Affiliated Hospital of Yunnan University, The First People's Hospital of Yunnan, The Fourth Affiliated Hospital of Zhejiang University, Third Affiliated Hospital, Sun Yat-Sen University, First Affiliated Hospital of Chongqing Medical University
COVID-19, Liver Disease, Vaccine Reaction
01/22
05/22
NMCIDCHESS2201, NCT05204602: Safety and Immunogenicity of COVID-19 Vaccine Booster in Patients With Liver Diseases

Recruiting
N/A
1000
RoW
Huashan Hospital, LanZhou University, Xingtai People's Hospital, The Third Central Hospital of Tianjin, The Third People's Hospital of Taiyuan, Lishui Country People's Hospital, Baoding People's Hospital, The Affiliated Hospital of Qingdao University, Nanjing Hospital of Chinese Medicine affiliated to Nanjing University of Chinese Medicine, The Fifth People's Hospital of Wuxi, Jincheng People's Hospital, The Sixth Peoples Hospital of Shenyang, Zhenjiang Third Hospital, The Third People's Hospital of Linfen City, The First Affiliated Hospital of Dalian Medical University, The Fourth People's Hospital of Qinghai Province, The Third People's Hospital of Tibet Autonomous Region, The Second Affiliated Hospital of Chongqing Medical University, Peking University Health Science Center, The Affiliated Hospital Of Southwest Medical University
COVID-19, Vaccine Reaction, Liver Diseases
08/22
12/22
NCT05965128: Promotion and Application of a New Three-level Etiological Diagnosis Strategy for Fever Clinics in Respiratory Infectious Diseases

Recruiting
N/A
1255
RoW
Huashan Hospital
Respiratory Infectious Diseases
12/23
12/27
NCT04676815: Narrow Band Imaging (NBI) Under Electronic Bronchoscope in Lung Cancer

Not yet recruiting
N/A
200
RoW
NBI and interventional bronchoscopy
Shanghai Pulmonary Hospital, Shanghai, China
Lung Cancer, Malignant Airway Obstruction
12/23
07/24
NCT04546360: Spleen Stiffness Combined With Liver Stiffness Measured by 2D-SWE for the Screening of High-risk Varices in Compensated Advanced Chronic Liver Disease (CHESS2004)

Completed
N/A
381
RoW
Esophagogasrtoduodendoscopy, spleen stiffness measurement and liver stiffness measurement.
Hepatopancreatobiliary Surgery Institute of Gansu Province, LanZhou University, Tianjin Second People's Hospital, The Sixth People's Hospital of Shenyang, Hospital of the Chengdu Office of the People's Government of Tibet Autonomous Region, The Central Hospital of Lishui City, Guangxi Zhuang Autonomous Region
Compensated Advanced Chronic Liver Disease, Variceal Hemorrhage
12/22
12/22

Download Options